Feb 12, 2026

1. Subject: Breaking News: FDA Refuses to Review Moderna’s Flu Shots

   Content: The FDA has refused to review Moderna’s application for a new influenza vaccine. Top FDA official Vinay Prasad cited that the submitted study was not “adequate and well-controlled,” a decision that raises questions about the agency’s stance on vaccines under the current policies. This refusal is a significant development as Moderna attempted to extend the use of its mRNA technology from COVID-19 vaccines to influenza. Further analysis on this decision can be found at STAT.

2. Subject: Affordability Drives Changes in Thai Healthcare & Fertility Breakthroughs at HKUMed

   Content: The Thai healthcare market sees institutional exits driven by affordability challenges, with patient shifts to public hospitals limiting private healthcare growth to 3%. Meanwhile, increased demand for preventive care is boosting the dental equipment market, particularly therapeutic dental equipment. HKUMed has made a notable fertility breakthrough by repurposing the kidney drug Finerenone to revive egg development. The Healthcare Asia Summit 2026 will discuss digital transformation and AI adoption across Asia’s health systems.

3. Subject: Vaccine Rejection & Harm Reduction Settlements Highlighted

   Content: The FDA’s refusal to review Moderna’s mRNA flu vaccine application has fueled debate around vaccine regulation under director Vinay Prasad’s leadership. Confidence in the safety of flu, COVID-19, and MMR vaccines is reportedly decreasing according to recent polling by the University of Pennsylvania’s Annenberg Public Policy Center. Additionally, a landmark legal settlement in Washington state affirms that harm reduction programs such as syringe exchanges are protected under the Americans with Disabilities Act, ensuring continued access to lifesaving services for drug users.

4. Subject: Obesity Drug Controversies and Health Coverage Burdens Revealed

   Content: An intensifying regulatory showdown is underway concerning compounded GLP-1 weight-loss drugs, including legal action against telehealth company Hims & Hers following FDA warnings. This dispute impacts the availability of less expensive copycat versions of blockbuster obesity treatments. Additionally, new analysis finds health insurance costs consume more than 10% of median family incomes in 19 US states, with premiums alone deemed unaffordable in several states. Public health leaders like Mehmet Oz urge vaccination amid measles outbreaks despite ongoing vaccine skepticism fueled by administration policies.

5. Subject: Limited Time Offer: 50% Off STAT+ Annual Subscriptions

   Content: Access cutting-edge insights into biotech, pharma, and life sciences with a 50% discount on STAT+ annual subscriptions through February 21, 2026. Benefits include unlimited access to premium research, exclusive newsletters, real-time breaking news alerts, expert coverage, custom data tools, and event discounts. Stay fully informed on emerging trends such as generative AI, obesity drugs, CRISPR, and FDA device approvals with STAT+.

6. Subject: Exclusive: Vinay Prasad Overrules FDA Staff to Reject Moderna’s Flu Vaccine Application

   Content: Breaking inside information reveals that FDA official Vinay Prasad personally overruled career scientists and vaccine office head David Kaslow, who were prepared to review Moderna’s influenza vaccine application. Despite the readiness of FDA reviewers, Prasad issued a refusal-to-file, ending the agency’s review prior to evaluation of the submitted evidence. This decision exemplifies increasing tensions within the FDA under Prasad’s direction regarding vaccine regulation.

7. Subject: Could Our Galaxy Center Contain Dark Matter Instead of a Black Hole?

   Content: Astrophysicists propose that the Milky Way’s center, traditionally thought to harbor a supermassive black hole, might instead contain a dense blob of fermionic dark matter surrounded by a diffuse cloud. This novel hypothesis fits 2022 observations equivalently well and could reshape understanding of galactic dynamics. Additional top science stories include newly deciphered ancient Roman board game rules, sibling rivalry studies in baboons, and calls for a ‘peace first’ approach in aid policy. Nature Briefing provides comprehensive coverage of these developments in science, technology, and society.

Stay Well!